Not only do we halt the growth of fat cells and restore the bodys ability to burn fat, but we also allow for that unneeded fat to be broken down (via increased production of the Sirt1 enzyme) and be excreted from the body
Symptoms can include: skin reactions such as Stevens-Johnson syndrome (painful sores on your mouth, throat, eyes, or genitals) anaphylaxis (a type of severe allergic reaction that can include low pulse rate, rash, sudden drop in blood pressure, and difficulty breathing) angioedema (swelling under your skin, typically in your eyelids, lips, hands, or feet) Kidney problems
A liverfirst approach includes: Confirming liver involvement with imaging and fibrosis assessments Evaluating comorbid metabolic conditions Tailoring lifestyle guidance to support hepatic outcomes Initiating GLP1s where appropriate for both metabolic and liver health Monitoring ALT/AST and noninvasive fibrosis scores alongside traditional outcomes Even in patients with normal A1C or lean body type, these therapies can play a role
Across studies of adults with type 2 diabetes designed to measure A1C reduction, average body weight changes ranged from 7.1 lb to 14.1 lb, though some participants gained weight
